Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sihang Liu
Institution:
Bristol-Myers Squibb (United States)
Observed institution:
Bristol-Myers Squibb (United States)
ORCID:
0009-0008-7834-9807
Observed ORCID:
0009-0008-7834-9807
OpenAlex ID:
A5102858513
Nivolumab and ipilimumab population pharmacokinetics in support of pediatric dose recommendations—Going beyond the body‐size effect
2023
·
Zheyi Hu
, Sihang Liu
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
5
PDF
Pediatric model‐based dose optimization using a pooled exposure–response safety analysis for nivolumab and nivolumab plus ipilimumab combination in melanoma
2023
·
Shengnan Du
, Yue Zhao
, et al.
·
CPT Pharmacometrics & Systems Pharmacology
·
4
PDF
Show more works
View as search
Works count:
2
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type